Alx Oncology Holdings (ALXO) Preferred Dividend Payments (2019 - 2020)
Alx Oncology Holdings recorded quarterly Preferred Dividend Payments of $578000.0 in Q3 2020, down 78.11% quarter-over-quarter from $2.6 million in Q2 2020, and down 46.03% year-over-year from $1.1 million in Q4 2019.
Alx Oncology Holdings' Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $578000.0 for Q3 2020.
- In Q3 2020, Preferred Dividend Payments fell 46.03% year-over-year to $578000.0; the TTM figure through Dec 2020 stood at $5.2 million (changed N/A YoY), while the FY2020 annual figure was $5.2 million, up 29.15% from the prior year.
- Preferred Dividend Payments came in at $578000.0 for Q3 2020 at Alx Oncology Holdings, down from $2.6 million in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $2.6 million in Q2 2020 to a low of $578000.0 in Q3 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Alx Oncology Holdings | 189.80 Mn | 49.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 578,000.00 |
| Jun 30, 2020 | 2.64 Mn |
| Mar 31, 2020 | 1.98 Mn |
| Dec 31, 2019 | 1.07 Mn |
| Sep 30, 2019 | 1.07 Mn |
| Jun 30, 2019 | 981,000.00 |